About This Page
This is a clinician-written, evidence-based guide aligned to the MCC Examination Objectives. It is structured by clinical presentation — the way the MCCQE tests and the way patients actually present. Management reflects current Canadian guidelines (CMA, CFPC, CPS). Always cross-reference with institutional protocols and clinical judgment.
The Bottom Line
- For ascites, MCCQE1 usually tests the first safe next step rather than obscure tests
- The differential diagnosis table is the centrepiece: prioritize emergency causes before common benign causes
- Initial investigations should be targeted to physiology, pregnancy status when relevant, organ pattern and Canadian practice pathways
- Management depends on severity: resuscitate unstable patients, treat reversible causes and involve specialists early when red flags are present
- For MCCQE1, focus on the next best step, CanMEDS communication/safety-netting and Canadian rather than US/UK guideline patterns
Approach to the Presentation
Ascites is assessed as a clinical presentation rather than as a named diagnosis. The first task is to identify instability, red flags and immediately reversible threats. Then classify the syndrome by timing, associated symptoms, examination findings and dominant organ pattern. In Canadian MCCQE1-style questions, the safest pathway is usually to stabilize first, rule out must-not-miss causes, use targeted investigations rather than shotgun testing, and give clear follow-up and safety-net advice.
Differential Diagnosis
| diagnosis | likelihood | key features | distinguishing test |
|---|---|---|---|
| Cirrhosis / Portal Hypertension | must-not-miss | Ascites with jaundice, spider naevi, splenomegaly, thrombocytopenia | Paracentesis SAAG >=11 g/L; ultrasound liver/portal flow |
| Spontaneous Bacterial Peritonitis | must-not-miss | Cirrhosis ascites with fever, pain, encephalopathy or renal dysfunction; may be subtle | Ascitic PMN >=250 cells/mm3; culture in blood culture bottles |
| Malignant Ascites | must-not-miss | Weight loss, anorexia, early satiety, ovarian/GI/pancreatic cancer risk | SAAG often <11 g/L, high protein; cytology and CT |
| Heart Failure / Constrictive Pericarditis | must-not-miss | Ascites with raised JVP, oedema, dyspnoea, hepatomegaly | BNP/echo; high SAAG/high protein |
| Budd-Chiari / Portal Vein Thrombosis | must-not-miss | Abdominal pain, hepatomegaly, ascites, hypercoagulable state | Doppler ultrasound/CT/MRI hepatic and portal veins |
| Nephrotic Syndrome | common | Generalized oedema, frothy urine, low albumin | Urinalysis, protein:creatinine ratio, albumin |
| Tuberculous Peritonitis | less common | Fever, night sweats, weight loss, TB exposure | Ascitic lymphocytes, ADA, AFB culture/PCR, biopsy |
| Pancreatic Ascites | less common | Pancreatitis/alcohol history, high ascitic amylase | Ascitic amylase; CT/MRCP/ERCP |
| Chylous Ascites | rare | Milky fluid, lymphoma, trauma or surgery | Ascitic triglycerides, cytology/imaging |
Red Flags & Key History
Symptoms
Haemodynamic instability, syncope, confusion, severe pain or sepsis physiology
Weight loss, anaemia, bleeding, progressive symptoms or persistent vomiting
Fever, night sweats, jaundice, nocturnal symptoms or immunocompromise
Pregnancy, anticoagulation, diabetes, frailty or major comorbidity lowering threshold for urgent care
Typical benign pattern without systemic features can be managed stepwise but still needs safety-netting
Signs
Shock, peritonism, focal neurological deficit, asterixis, crepitus or mass — urgent pathway
Pallor, cachexia, lymphadenopathy, ascites or organomegaly
Localized tenderness, abnormal rectal/pelvic findings or jaundice
Normal examination does not exclude early serious disease when history is concerning
Approach to Investigation
First-line
Focused bedside assessmentVital signs, hydration, pain severity, mental status, medication review and pregnancy testing when relevant.
CBC, electrolytes/creatinine and targeted chemistryDetect anaemia, infection, AKI, electrolyte disturbance and organ pattern.
Presentation-specific first-line testUse ultrasound, endoscopy, stool testing, ECG/troponin, urinalysis or liver panel depending on syndrome.
Risk stratificationUse Canadian practice patterns and validated tools when applicable.
Second-line
Targeted imagingUltrasound, CT, MRI/MRCP or CT angiography based on suspected anatomy and urgency.
Endoscopy/colonoscopy with biopsyWhen mucosal disease, bleeding, dysphagia, malignancy, IBD or unexplained alarm features are present.
Specialized serology/stool/functional testsUse when inflammatory, infectious, autoimmune, malabsorptive or motility disorders are suspected.
Specialist
Urgent specialty referralFor unstable patients, cancer concern, major bleeding, sepsis, obstruction, liver failure or failed outpatient management.
Therapeutic procedureDrainage, dilation, ERCP, embolization, paracentesis, surgery or biopsy when indicated.
Management Principles
Canadian guideline-based approach + MCC objectives1
Stabilize and triage
- Assess ABCs, vital signs, hydration, pain and mental status
- Treat shock, sepsis, bleeding, severe electrolyte derangement or obstruction immediately
- Do not delay urgent specialist involvement when red flags are present
2
Treat likely cause
- Use presentation-specific therapy after excluding must-not-miss conditions
- Review medications, anticoagulants, alcohol, supplements and pregnancy status
- Provide analgesia, antiemesis, hydration and nutrition support as required
3
Follow-up and prevention
- Arrange appropriate endoscopy/imaging/referral and ensure results are tracked
- Give clear safety-net advice and revisit diagnosis if symptoms progress
- Address screening, vaccination, lifestyle or recurrence prevention where relevant
Complications & Pitfalls
- Premature closure: benign explanations must not override red flags.
- Missing physiology: unstable patients need resuscitation before definitive diagnosis.
- Ignoring medications: NSAIDs, anticoagulants, opioids, antibiotics and supplements often matter.
- No follow-up loop: abnormal results and persistent symptoms need active tracking.
MCCQE1 Exam Tips
- 1For ascites, MCCQE1 usually tests the first safe next step rather than obscure tests
- 2Start with stability and red flags, then use the presentation-specific differential
- 3Do not anchor on common benign causes when weight loss, bleeding, anaemia, fever or progressive symptoms are present
- 4Use Canadian guideline language and Canadian spelling/drug names
- 5Know when to involve gastroenterology, surgery, oncology, hepatology or emergency medicine
- 6Safety-netting and follow-up are CanMEDS communication and professional responsibilities
practicetest your knowledge on ascitesApply what you've learnt with MCCQE1-style questions from the iatroX Q-Bank — gastrointestinal and beyond.
open q-bank